Un listing de conférences scientifiques et techniques

Accueil | Logiciel de gestion de conférence | Calendrier des conférences | Annonces publicitaires | Nous contacter | Qui nous sommes
Deutsch Français English
Vous êtes ici: AccueilCalendrier des conférencesSoins de santé → Pharmacologie et développement des médicaments - États-Unis

Logiciel de gestion de conférences

Notre système de gestion de conférences en ligne (COMS) vous permet de:

  • gérer l'organisation de la conférence en ligne
  • gérer les inscriptions
  • gérer les paiements
  • gérer les soumissions de présentations
  • gérer la procédure de revue
  • sélectionner les présentations
  • produire le livre des résumés

Pour en savoir plus ...

Conférences - Pharmacologie et développement des médicaments - États-Unis met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.SPS 14th Annual Meeting — Safety Pharmacology Society 14th Annual Meeting
 Dates 19 Oct 2014 → 22 Oct 2014
[ID=625974] Haut de la page
 LieuWashington, DC, États-Unis
 Résumé The Safety Pharmacology Society (SPS) 14th Annual Meeting will be held October 19–22, 2014, in Washington, DC and will provide a dynamic forum for sharing the latest in safety pharmacology. The scientific program will offer in-depth discussions of relevant topics to keep you “in the know.” This meeting will feature a diverse range of scientific sessions organized into two tracks, covering issues such as, Cardiovascular, Central Nervous System, Non Cardiac Ion Channels, Respiratory, Regulatory, New Assays, Peripheral Neuropathy, and an all day Plenary on Wednesday covering the Updates and Perspectives on Comprehensive In Vitro Proarrhythmia Assay (CIPA). The meeting also will offer a full day of Continuing Education courses on October 19, both on an introductory level as well as advanced courses for the expert, and the Diplomate in Safety Pharmacology (DSP) Certification exam will be held the day before the meeting on October 18.
 Sujets Cardiovascular, Central Nervous System, Non Cardiac Ion Channels, Respiratory, Regulatory, New Assays, Peripheral Neuropathy, Comprehensive In Vitro Proarrhythmia Assay (CIPA)
 Page web
 Contact Tél.: [7035470874]; Email.:
2.65th American Association for Laboratory Animal Science National Meeting
 Dates 19 Oct 2014 → 23 Oct 2014
[ID=633380] Haut de la page
 LieuSan Antonio, États-Unis
 Page web
3.Drug Discovery USA Congress — Drug Discovery USA Congress
 Dates 21 Oct 2014 → 22 Oct 2014
[ID=629017] Haut de la page
 LieuBoston, États-Unis
 Résumé This congress brings together over 150 senior experts to discuss recent developments in drug discovery and medicinal chemistry. Topics covered include screening technology, drug design, assay development, external innovation access, computational chemistry and discovery informatics.
 Sujets Drug Discovery, Drug Design, Assay Development, External Innovation Access, Computational Chemistry, Discovery Informatics, Screening Technology
 Page web
 Contact Danielle Dalby; Tél.: [+44 (0) 1865 248455]; Email.:
4.PsychPharm — Psychopharmacology Update
 Date de début25 Oct 2014
[ID=631349] Haut de la page
 LieuCincinnati, États-Unis
 Résumé This activity is designed for child and adolescent psychiatrists, general psychiatrists, geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers, and other mental health professionals interested in treating patients with psychiatric disorders to remission with measurement based care.
 Page web
 Contact Kim Kirchner , Registration Coordinator , Global Academy for Medical Education ; Tél.: [(502) 574-9023]; Email.:
 Sujets apparentés Psychiatrie
5.VACC14 — 8th Vaccine & ISV Congress
 Dates 26 Oct 2014 → 28 Oct 2014
[ID=612996] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé Join us in Philadelphia for the premier conference on vaccines and vaccination. The 8th Vaccine & ISV Congress will feature science and public health topics, from primary vaccine research and vaccine manufacturers, to governmental policy, safety and regulation. If you work as a researcher in vaccine-related topics, in the vaccine industry, or in vaccine policy making, this is your must-attend event in 2014.
 Sujets Human vaccines - infectious diseases, Human vaccines - non-infectious diseases, Veterinary vaccines, Vaccine safety, Clinical studies and field trials, Immunology, animal models, Vectors, adjuvants, drug delivery, Production, manufacturing, Regulatory, societal, economic, programmatic, legislation subjects
 Page web
6.Re-Entering Antibacterial Drug Development Summit
 Dates 27 Oct 2014 → 29 Oct 2014
[ID=628969] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Several factors including diminishing financial return, lack of new discovery platforms and others, had a cooling effect on pharmaceutical companies' activity in the area of antibacterial drug development. At the same time, we are witnessing the wide spread of resistant bacteria, leading to untreatable infections. "We are facing a huge crisis worldwide not having an antibiotics pipeline," said Dr. Janet Woodcock, Director of CDER at FDA, in her recent interview to NYT. The governments of European countries and the United States have created several incentives for the industry to rise to the challenge. Therefore, many companies are exploring the opportunities to start or re-open their antibacterial departments, or to stimulate the existing research and development. Cambridge Healthtech Institute is pleased to present its inaugural Re-Entering Antibacterial Drug Development Summit that includes a science track and a business track, and features a wide range of pivotal issues. The Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders shaping the current state of antibacterial discovery and development.
 Sujets drug development, antibacterial discovery, antibacterial development, discovery platforms, pharmaceutical, antibiotics, antibacterial departments, antibacterial research
 Page web
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.:
7.Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
 Dates 27 Oct 2014 → 29 Oct 2014
[ID=629726] Haut de la page
 LieuBoston, Massachusetts, États-Unis
 Résumé This course focuses on practical approaches to accelerated QbD implementation, and it makes practical recommendations for realistic implementation of QbD elements. Participants will learn how to prioritize process parameters for screening designs, how to design robust processes using statistical design of experiments (DoE), how to bridge the bench and the commercial design spaces using mixing and scale-up calculations, how to quantify process risk, how to select suitable process analytical technology tools (PAT) and more. For the benefit of process scientists, engineers, formulators, analytical chemists and manufacturing personnel, this course includes highly interactive, hands-on workshops, based on several case studies. Effective technology transfer to pilot and manufacturing plants is also discussed, including process validation in the QbD paradigm.
 Sujets Organic Chemistry
 Page web
 Sujets apparentés Génie chimique
8.2nd The Pharmacovigilance & Risk Management Strategies
 Dates 28 Oct 2014 → 29 Oct 2014
[ID=641834] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé The Pharmacovigilance & Risk Management Strategies Conference is bringing together experts and industry leaders who will discuss the most important issues and challenges regarding Global Pharmacovigilance and Benefit-Risk Analysis. Some of the main topics will include the impact of the new EMA and FDA regulations, Social Media, Adverse Event Reporting, Signal Detection, and Benefit-Risk & Risk Management.
 Sujets pharmacovigilance drug safety drug development risk management pharmacovigilance strategies
 Page web
 Contact Lawrence Smithson; Tél.: [+13125824273]; Email.:
 Sujets apparentés Législation en médecine et pharmacologie
9.Practical Approaches to Statistical Design of Experiments (DoE)
 Dates 30 Oct 2014 → 31 Oct 2014
[ID=629789] Haut de la page
 LieuBoston, Massachusetts, États-Unis
 Résumé This course takes a balanced approach presenting basic DoE theory as well as numerous examples of DoE use in the pharmaceutical industry. The course will discuss statistical and practical significance, assumptions and limitations of DoE methodology, together with practical approaches for the process scientist to be in control of the DoE investigation (and not the computer).
 Sujets Organic Chemistry
 Page web
10.CHEMOTHERAPY FOUNDATION SYMPOSIUM: Innovative Cancer Therapy for Tomorrow®
 Dates 05 Nov 2014 → 07 Nov 2014
[ID=623166] Haut de la page
 LieuNew York, États-Unis
 Résumé CHEMOTHERAPY FOUNDATION SYMPOSIUM, Innovative Cancer Therapy for Tomorrow®, is a CME accredited educational activity jointly presented by the Icahn School of Medicine at Mount Sinai and the Chemotherapy Foundation, a non-profit organization supporting cancer research, in collaboration with The Tisch Cancer Institute. Founded in 1972 by Ezra Greenspan, we continue to bring the groundbreaking advances spearheading progress in cancer therapeutics to community and academic practitioners. Leading oncologist and hematologist investigators will report on new regimens, clinical trials and emerging therapeutic advances in common cancer types.
 Sujets Cancer, Chemotherapy, Oncology, Hematology, Breast Cancer, Gynecological Oncology, Surgical Oncologists, Pediatric Oncology, Radiotherapy, Immunology, Oncology Nurses, Case Managers, Pharmacists
 Page web
 Contact Tél.: [212 866 2813]; Email.:
 Sujets apparentés Cancérologie; Hématologie
11.2014 Chabner Colloquium: Collaboration in Cancer Drug Trials
 Dates 10 Nov 2014 → 11 Nov 2014
[ID=637826] Haut de la page
 LieuBoston, États-Unis
 Résumé The Society for Translational Oncology (STO) and the Massachusetts General Hospital Cancer Center (MGHCC), will host the 2014 Chabner Colloquium at The Liberty Hotel in Boston, Massachusetts on Monday-Tuesday, November 10-11, 2014. This meeting will focus on topics that bring cancer biology to clinical application and will feature a thoughtful look at the potential for collaboration between academia and industry with a focus on immuno-oncology and new therapeutic targets.
 Sujets Professional, Blood Cancer, Cancer Biology , Cancer, Diagnostics and Molecular Pathology, Clinical Pharmacology , Gastrointestinal Cancer, Genitourinary Cancer Prostate, Geriatric Oncology, Leukemias, Lung Cancer, Melanoma and Cutaneous Malignancies, New Drug Development and Clinical Pharmacology, Sarcomas, Lecture, Course
 Page web
 Contact Email.:
 Sujets apparentés Cancérologie; Essais cliniques
12.2nd International mRNA Health Conference
 Dates 11 Nov 2014 → 12 Nov 2014
[ID=639543] Haut de la page
 LieuCambridge, MA, États-Unis
 Résumé The 2nd International mRNA Health Conference, which will be held on November 11 and 12, 2014, in Boston, Massachusetts, will bring together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. During the two-day event, colleagues from around the world will share the vanguard of research and technologies poised to unlock the tremendous medical potential of mRNA for many therapeutic indications.
 Page web
 Contact Victoria Drizin-Sirotin; Tél.: [Phone: +1 (617) 209-5835]; Email.:
13.3rd Pharmacovigilance & Risk Management Strategies
 Dates 11 Nov 2014 → 12 Nov 2014
[ID=642891] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé The Pharmacovigilance & Risk Management Strategies Conference is bringing together experts and industry leaders who will discuss the most important issues and challenges regarding Global Pharmacovigilance and Benefit-Risk Analysis. Some of the main topics will include the impact of the new EMA and FDA regulations, Social Media, Adverse Event Reporting, Signal Detection, and Benefit-Risk & Risk Management.
 Sujets pharmacovigilance drug safety drug development risk management FDA regulations
 Page web
 Contact Lawrence Smithson; Tél.: [+13125824273]; Email.:
 Sujets apparentés Législation en médecine et pharmacologie
14.2014 NEI Psychopharmacology Congress
 Dates 13 Nov 2014 → 16 Nov 2014
[ID=642761] Haut de la page
 LieuColorado Springs, États-Unis
 Page web
 Sujets apparentés Neurologie; Psychiatrie
15.FAST: Functional Analysis & Screening Technologies Congress
 Dates 17 Nov 2014 → 19 Nov 2014
[ID=632406] Haut de la page
 LieuBoston, MA, États-Unis
 Résumé Join our community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery.
 Sujets drug discovery, toxicology, phenotypic, cellular tumor models
 Page web
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.:
16.Clinical Pharmacy-2014 — 2nd International Summit on Clinical Pharmacy
 Dates 02 Dec 2014 → 03 Dec 2014
[ID=613127] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé Clinical Pharmacy-2014 is a unique event which forms a network with leading pharmacy doctors, researchers, industry professionals, scientists, pharmacists and scholar students to exchange and share their experiences, new ideas and research results about all aspects of Clinical Pharmacy and to discuss the practical challenges encountered and the solutions adopted.

2nd International Summit on Clinical Pharmacy provides opportunities for the delegates to exchange new ideas and new application experiences directly, to establish research relations and to find global partners for future collaboration. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies about Clinical Pharmacy. By attending this prestigious event you will be enlightened with innovative ideas and solutions and take initiatives to find better education in the biomedical, pharmaceutical, sociobehavioral and clinical sciences.

 Sujets General Clinical Pharmacology, Pharmacists Role in Patient Safety, Clinical Pharmacy and Its Key Role in Treatment, Dispensing Pharmacy and Research Chemists
 Page web
 Contact Tél.: [1-650-268-9744]; Email.:
17.3rd Immunogenicity and Immunotoxicity Conference
 Dates 29 Jan 2015 → 30 Jan 2015
[ID=647280] Haut de la page
 LieuSan Diego, États-Unis
 Résumé GTC is proud to announce its 3rd Immunogenicity and Immunotoxicity Conference, one of four parallel tracks to the Novel Immunotherapeutics Summit 2015 on January 29-30, 2015 in San Diego, CA. The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.

The Immunogenicity and Immunotoxicity Conference will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

 Page web
 Contact Tél.: [626-256-6405]; Email.:
18.Pharmacokinetics for Pharmaceutical Scientists Course
 Dates 02 Fév 2015 → 06 Fév 2015
[ID=651390] Haut de la page
 LieuSan Francisco, États-Unis
 Page web
19.SLAS 2015 — Conference and Exhibition of the Society for Laboratory Automation and Screening
 Dates 07 Fév 2015 → 11 Fév 2015
[ID=646861] Haut de la page
 LieuWashington, D.C., États-Unis
 Résumé The SLAS scientific program is geared especially towards life science research and development professionals whose interests include: drug discovery and development, assay development and screening, laboratory automation and high-throughput technologies, micro-nano technologies, molecular diagnostics and biomarkers, scientific informatics, bioanalytical techniques, and drug target biology. SLAS2015 offers participants a world-class scientific program that showcases the top laboratory science and technology podium presentations delivered by leading authorities from industry, academic and government backgrounds from around the world. Each podium presentation is diligently selected by the SLAS2015 Annual Conference Program Committee from hundreds of abstract submissions. These presentations offer SLAS2015 participants compelling content and new perspectives on emerging laboratory technologies customized for life science research and development professionals whose interests include: drug discovery and development,, assay development and screening,, laboratory automation and high-throughput technologies,, micro-nano technologies,, molecular diagnostics and biomarkers,, scientific informatics,, bioanalytical techniques,, and drug target biology..
 Page web
 Sujets apparentés Physique appliquée: Biophysique et génie biomédical; Foire exposition chimie,
20.Molecular Med TRI-CON 2015
 Dates 15 Fév 2015 → 20 Fév 2015
[ID=638670] Haut de la page
 LieuSan Francisco, États-Unis
 Résumé The 22nd International Molecular Medicine Tri-Conference is the industry's Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.
 Sujets biotech, biotechnology, information technology, diagnostics, genomics, drug discovery
 Page web
 Contact Kris Waterman ; Tél.: [(781-972-5400)]; Email.:
 Sujets apparentés Biotechnologie
21.EDD — Enzymes in Drug Discovery Conference
 Dates 25 Fév 2015 → 27 Fév 2015
[ID=650584] Haut de la page
 LieuSan Diego, Californie, États-Unis
 Résumé We welcome you to GTCbio's Inaugural Enzymes in Drug Discovery Conference, which will be held on February 25 - 27, 2015 in San Diego, CA.
 Sujets Enzyme Structures, Drug Targets
 Page web
 Contact Global Technology Community 635 W. Foothill Blvd, Monrovia, CA 91016 Phone: 626-256-6405 Fax: 626-466-4433; Tél.: [6262566405]; Email.:
22.Biotherapeutics Analytical Summitt
 Dates 09 Mar 2015 → 13 Mar 2015
[ID=639433] Haut de la page
 LieuBaltimore, États-Unis
 Résumé The first part of this conference focuses on Advances with Analytical Methods. Part Two of Analytical Characterization focuses on application of analytical technologies for a range of products including ADCs and multi-specifics.The Comparability for Biologics conference brings together scientists and engineers from core analytical lab, drug development, process sciences, formulation, manufacturing, QA/QC and regulatory affairs to share strategies, approaches and technologies that will help overcome these comparability questions and challenges.
 Sujets biotech, biotechnology, analytical methods, analytical characterization, analytical technologies, biologics
 Page web
 Contact Kris Waterman; Tél.: [781-972-5400]; Email.:
23.7th Ocular Diseases Drug Discovery Conference
 Dates 19 Mar 2015 → 20 Mar 2015
[ID=661654] Haut de la page
 LieuSan Diego, États-Unis
 Résumé 7th Ocular Diseases Drug Discovery Conference is taking place on March 19-20, 2015 in San Diego, CA. The conference continues to offer presentations on novel therapeutics in ocular drug development and discovery. This is a platform for excellent networking, exchanging ideas, and sharing challenges; all with a united goal of bringing innovative and progressive treatments to patients in the field of ophthalmology. The conference promotes the discovery of drug development and therapeutics in ocular diseases by gathering leading scientists, researchers, and experts to discuss and collaborate on the latest R&D, safety assessment, regulatory issues, and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), uveitis, and other ocular diseases.
 Page web
 Contact; Tél.: [(6262566405)]; Email.:
 Sujets apparentés Ophtalmologie
24.Pharma Nutrition 2015
 Dates 13 Avr 2015 → 15 Avr 2015
[ID=647822] Haut de la page
 LieuPhiladelphia, États-Unis
 Résumé Pharma-Nutrition is entirely dedicated to discussing the latest research, concepts and applications of medical nutrition in patient treatment and disease management. This conference will uniquely integrate the presentations on the role of the human microbiome and how it impacts both pharma and nutritional approaches in disease outcomes. This international conference is your opportunity to learn and share research, and to meet and network with your peers across the community of pharmacology, nutrition specialists and microbiome experts who work on the interface of pharma-nutrition.
 Page web
 Sujets apparentés Chimie alimentaire et agronomie
25.Gordon Research Conference — Preclinical Form & Formulation for Drug Discovery 2015
 Dates 07 Jui 2015 → 12 Jui 2015
[ID=655595] Haut de la page
 LieuWaterville Valley, États-Unis
 Résumé The goals of the conference are to bring together academic and industry leaders in pharmaceutical materials science, preclinical formulation science, automation science, biopharmaceutics and relevant applicable technologies to: Share methodologies that enable evaluation of potential drug candidates stagnating due to physical form and/or formulation challenges; Facilitate scientific and technological advances to increase efficiency in selection of formulations for preclinical and early clinical studies; Envision ways that science & technology could transform the current state in this area; Identify further knowledge gaps in scientific understanding and technological capabilities associated with this topic that can be discussed at future conferences. The conference will highlight topics on maximizing exposure of potential drugs and compounds used in affecting relevant biological targets. Methodologies that can improve physical properties of materials, novel formulations that can help improve exposure, computational methodologies that can aid in compound selection and behavior, and instrumentation technologies that can be applied will be explored. 
 Page web
26.Stress and Behavior — 5th International Regional "Stress and Behavior" Neuroscience and Biopsychiatry Conference (North America)
 Dates 22 Jui 2015 → 24 Jui 2015
[ID=634027] Haut de la page
 LieuMiami, États-Unis
 Résumé An annual international event gathering scientists and psychiatrists from around the world to share an interest in stress-evoked brain disorders in both humans and animals.
 Sujets stress, behavior, neuroscience, psychiatry, biopsychiatry, genetics, pharmacology, anxiety, mental health
 Page web
 Contact NA Nutsa, Conference Secretary , International Stress and Behavior Society; Tél.: [12408999571]; Email.:
 Sujets apparentés Psychiatrie
27.Gordon Research Conference — Drug Metabolism 2015
 Dates 12 Jul 2015 → 17 Jul 2015
[ID=647981] Haut de la page
 LieuHolderness, États-Unis
 Résumé The Drug Metabolism Gordon Research Conference (GRC) provides an intimate forum for the discussion of the diverse topics of this field. The meeting provides an ideal opportunity for young researchers to expand their scientific horizons, and graduate students and postdocs are encouraged to apply.
 Page web
 Sujets apparentés Biologie; Médecine (en général)
28.Gordon Research Conference — Computer Aided Drug Design 2015
 Dates 19 Jul 2015 → 24 Jul 2015
[ID=648139] Haut de la page
 LieuWest Dover, États-Unis
 Résumé The Gordon Research Conference on Computer-Aided Drug Design has been a premier conference in its field for more than three decades. During this period, there has been an ever-increasing interest in the application of computation to drug discovery, ranging from the all-atom simulation of molecular systems to the canonicalization and organization of molecular information. Some approaches, in particular molecular informatics, are now cornerstones of any drug discovery process. Statistics, data mining, machine learning and related concepts pervade today's drug discovery and development activities. An ever-important aspect of such research is the evaluation of progress: Is one method actually better than another? The program will be an unusual mix of cutting-edge, largely unpublished work in computational drug discovery, and lectures from experts outside the field who can give a broader view of the fundamental problems listed above and thus can illuminate the field’s greatest opportunities.
 Page web
 Sujets apparentés Modélisation moléculaire

États-Unis: liste de tous les évènements/conférences.

Dernière mise à jour: 16 octobre 2014